Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

BACKGROUND: The DecisionDx-Melanoma test provides prognostic information for patients with cutaneous melanoma (CM). Using formalin-fixed paraffin-embedded primary tumor tissue, the RT-PCR-based test classifies patients into a low- (Class 1) or high-risk (Class 2) category for recurrence based on exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Robert W., Middlebrook, Brooke, Wilkinson, Jeff, Covington, Kyle R., Oelschlager, Kristen, Monzon, Federico A., Stone, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809902/
https://www.ncbi.nlm.nih.gov/pubmed/29433548
http://dx.doi.org/10.1186/s13000-018-0690-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809902/
https://www.ncbi.nlm.nih.gov/pubmed/29433548
http://dx.doi.org/10.1186/s13000-018-0690-3

Ejemplares similares